The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nolxado 40 mg/20 mg prolonged-release tablets

40mg / 20 milligram(s) Prolonged-release tablet

KRKA, d.d., Novo mestoPA1347/085/003

Main Information

Trade NameNolxado 40 mg/20 mg prolonged-release tablets
Naloxone hydrochloride dihydrate
Strength40mg / 20 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/085/003

Group Information

ATC CodeN02AA Natural opium alkaloids
N02AA55 oxycodone, combinations


Licence Issued19/05/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S. I. No. 328 of 1988) as amended.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0102-160-024
Interchangeable List DocumentPDF of Interchangeable List
« Back